StockData
Cardiol Therapeutics Inc. logo

Cardiol Therapeutics Inc. (CRDL) stock

CRDLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$0.86−0.02 (-2.28%)

Close on Nov 20, 2026Market cap $86.48MP/E –Yield –

Cardiol Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Cardiol Therapeutics's price to sales ratio was 396.3× on Feb 28, 2023.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Feb 28, 2023396.3×+17.6
2022Dec 30, 2022378.7×–

More Cardiol Therapeutics figures

See a number that looks wrong?